Unique in its format covering the full bandwidth from fundamental science and technology to new products and clinical adoption, this 1-day conference will convene stakeholders from science, medicine and industry to discuss opportunities and challenges associated with the evolution of in vitro diagnostics towards a decentralized, boundary-less testing near the patient, thus further enabling personalized medicine.
Dr Antonella Santuccione Chadha, Women’s Brain Project CEO probono, will be giving a keynote talk on the topic of sex and gender determinants to health. An event hosted by the FHNW Muttenz , Switzerland.
